Instant Brands LLC; Analysis of Proposed Consent Order To Aid Public Comment, 3986-3987 [2023-01187]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
3986
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
FEDERAL RESERVE SYSTEM
FEDERAL TRADE COMMISSION
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
[File No. 222 3140]
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than February 7, 2023.
A. Federal Reserve Bank of Dallas
(Karen Smith, Director, Mergers &
Acquisitions) 2200 N Pearl St., Dallas,
TX 75201–2272 or electronically to
Comments.applications@dal.frb.org:
1. The Dakri Grandchildren’s 2022
GST Trust for Haaris A. Dakri, the Dakri
Grandchildren’s 2022 GST Trust for
Minor Child 1, the Dakri
Grandchildren’s 2022 GST Trust for
Minor Child 2, and Asif M. Dakri and
Faizel M. Dakri as co-trustees of the
aforementioned trusts, all of Houston,
Texas; to join the Dakri Family Control
Group, a group acting in concert, to
acquire voting shares of Wallis
Bancshares, Inc., and thereby indirectly
acquire voting shares of Wallis Bank,
both of Wallis, Texas.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–01197 Filed 1–20–23; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:44 Jan 20, 2023
Jkt 259001
Instant Brands LLC; Analysis of
Proposed Consent Order To Aid Public
Comment
Federal Trade Commission.
Proposed consent agreement;
request for comment.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair or
deceptive acts or practices. The attached
Analysis of Proposed Consent Order to
Aid Public Comment describes both the
allegations in the draft complaint and
the terms of the consent order—
embodied in the consent agreement—
that would settle these allegations.
DATES: Comments must be received on
or before February 22, 2023.
ADDRESSES: Interested parties may file
comments online or on paper by
following the instructions in the
Request for Comment part of the
SUPPLEMENTARY INFORMATION section
below. Please write ‘‘Instant Brands
LLC; File No. 222 3140’’ on your
comment and file your comment online
at https://www.regulations.gov by
following the instructions on the webbased form. If you prefer to file your
comment on paper, please mail your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW, Suite CC–5610 (Annex D),
Washington, DC 20580.
FOR FURTHER INFORMATION CONTACT: Julia
Ensor (202–326–2377), Bureau of
Consumer Protection, Federal Trade
Commission, 600 Pennsylvania Avenue
NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant
to section 6(f) of the Federal Trade
Commission Act, 15 U.S.C. 46(f), and
FTC Rule 2.34, 16 CFR 2.34, notice is
hereby given that the above-captioned
consent agreement containing a consent
order to cease and desist, having been
filed with and accepted, subject to final
approval, by the Commission, has been
placed on the public record for a period
of 30 days. The following Analysis to
Aid Public Comment describes the
terms of the consent agreement and the
allegations in the complaint. An
electronic copy of the full text of the
consent agreement package can be
obtained at https://www.ftc.gov/newsevents/commission-actions.
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before February 22, 2023. Write ‘‘Instant
Brands LLC; File No. 222 3140’’ on your
SUMMARY:
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
comment. Your comment—including
your name and your state—will be
placed on the public record of this
proceeding, including, to the extent
practicable, on the https://
www.regulations.gov website.
Because of heightened security
screening, postal mail addressed to the
Commission will be subject to delay. We
strongly encourage you to submit your
comments online through the https://
www.regulations.gov website.
If you prefer to file your comment on
paper, write ‘‘Instant Brands LLC; File
No. 222 3140’’ on your comment and on
the envelope, and mail your comment to
the following address: Federal Trade
Commission, Office of the Secretary,
600 Pennsylvania Avenue NW, Suite
CC–5610 (Annex D), Washington, DC
20580.
Because your comment will be placed
on the publicly accessible website at
https://www.regulations.gov, you are
solely responsible for making sure your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include sensitive personal information,
such as your or anyone else’s Social
Security number; date of birth; driver’s
license number or other state
identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure your
comment does not include sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including competitively sensitive
information such as costs, sales
statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
E:\FR\FM\23JAN1.SGM
23JAN1
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
has been posted on the https://
www.regulations.gov website—as legally
required by FTC Rule 4.9(b)—we cannot
redact or remove your comment from
that website, unless you submit a
confidentiality request that meets the
requirements for such treatment under
FTC Rule 4.9(c), and the General
Counsel grants that request.
Visit the FTC website at https://
www.ftc.gov to read this document and
the news release describing the
proposed settlement. The FTC Act and
other laws the Commission administers
permit the collection of public
comments to consider and use in this
proceeding, as appropriate. The
Commission will consider all timely
and responsive public comments it
receives on or before February 22, 2023.
For information on the Commission’s
privacy policy, including routine uses
permitted by the Privacy Act, see
https://www.ftc.gov/site-information/
privacy-policy.
Analysis of Proposed Consent Order To
Aid Public Comment
The Federal Trade Commission
(‘‘FTC’’ or ‘‘Commission’’) has accepted,
subject to final approval, an agreement
containing a consent order from Instant
Brands LLC (‘‘Respondent’’). The
proposed consent order has been placed
on the public record for 30 days for
receipt of comments from interested
persons. Comments received during this
period will become part of the public
record. After 30 days, the Commission
will again review the agreement and the
comments received and decide whether
it should withdraw from the agreement
or make final the agreement’s proposed
order.
This matter involves Respondent’s
advertising of Pyrex measuring cup sets
as ‘‘Made in USA.’’ According to the
FTC’s complaint, between May 2021
and March 2022, Respondent advertised
certain Pyrex measuring cup sets on
Amazon.com as ‘‘Made in USA’’ or
‘‘American as Apple Pie,’’ even though,
in numerous instances, those measuring
cup sets were wholly imported from
China. Based on the foregoing, the
complaint alleges Respondent violated
section 5 of the FTC Act, 15 U.S.C.
45(a).
The proposed consent order contains
provisions designed to prevent
Respondent from engaging in similar
acts and practices in the future.
Consistent with the FTC’s Made in USA
Labeling Rule, 16 CFR part 323, and its
Enforcement Policy Statement on U.S.Origin Claims, Part I prohibits
Respondent from making U.S.-origin
claims for its products unless: (1) the
final assembly or processing of the
VerDate Sep<11>2014
16:44 Jan 20, 2023
Jkt 259001
product occurs in the United States, all
significant processing that goes into the
product occurs in the United States, and
all or virtually all ingredients or
components of the product are made
and sourced in the United States; (2) a
clear and conspicuous qualification
appears immediately adjacent to the
representation that accurately conveys
the extent to which the product contains
foreign parts, ingredients or
components, and/or processing; or (3)
for a claim that a product is assembled
in the United States, the product is last
substantially transformed in the United
States, the product’s principal assembly
takes place in the United States, and
United States assembly operations are
substantial.
Part II prohibits Respondent from
making any representation about the
country of origin of a product or service,
unless the representation is not
misleading, and Respondent has a
reasonable basis substantiating it. Parts
III and IV are monetary provisions. Part
III imposes a judgment of $129,416. Part
IV includes additional monetary
provisions relating to collections.
Parts V through VIII are reporting and
compliance provisions. Part V requires
Respondent to acknowledge receipt of
the order, to provide a copy of the order
to certain current and future principals,
officers, directors, and employees, and
to obtain an acknowledgement from
each such person that they have
received a copy of the order. Part VI
requires Respondent to file a
compliance report within one year after
the order becomes final and to notify the
Commission within 14 days of certain
changes that would affect compliance
with the order. Part VII requires
Respondent to maintain certain records,
including records necessary to
demonstrate compliance with the order.
Part VIII requires Respondent to submit
additional compliance reports when
requested by the Commission and to
permit the Commission or its
representatives to interview
Respondent’s personnel.
Finally, Part IX is a ‘‘sunset’’
provision, terminating the order after
twenty (20) years, with certain
exceptions.
The purpose of this analysis is to aid
public comment on the proposed order.
It is not intended to constitute an
official interpretation of the proposed
order or to modify its terms in any way.
By direction of the Commission.
Joel Christie,
Acting Secretary.
[FR Doc. 2023–01187 Filed 1–20–23; 8:45 am]
BILLING CODE 6750–01–P
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
3987
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–0995]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘National
Network of Sexually Transmitted
Diseases Clinical Prevention Training
Centers’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on August
22, 2022 to obtain comments from the
public and affected agencies. CDC
received two comments. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility:
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
E:\FR\FM\23JAN1.SGM
23JAN1
Agencies
[Federal Register Volume 88, Number 14 (Monday, January 23, 2023)]
[Notices]
[Pages 3986-3987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01187]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
[File No. 222 3140]
Instant Brands LLC; Analysis of Proposed Consent Order To Aid
Public Comment
AGENCY: Federal Trade Commission.
ACTION: Proposed consent agreement; request for comment.
-----------------------------------------------------------------------
SUMMARY: The consent agreement in this matter settles alleged
violations of federal law prohibiting unfair or deceptive acts or
practices. The attached Analysis of Proposed Consent Order to Aid
Public Comment describes both the allegations in the draft complaint
and the terms of the consent order--embodied in the consent agreement--
that would settle these allegations.
DATES: Comments must be received on or before February 22, 2023.
ADDRESSES: Interested parties may file comments online or on paper by
following the instructions in the Request for Comment part of the
SUPPLEMENTARY INFORMATION section below. Please write ``Instant Brands
LLC; File No. 222 3140'' on your comment and file your comment online
at https://www.regulations.gov by following the instructions on the
web-based form. If you prefer to file your comment on paper, please
mail your comment to the following address: Federal Trade Commission,
Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC-5610
(Annex D), Washington, DC 20580.
FOR FURTHER INFORMATION CONTACT: Julia Ensor (202-326-2377), Bureau of
Consumer Protection, Federal Trade Commission, 600 Pennsylvania Avenue
NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant to section 6(f) of the Federal
Trade Commission Act, 15 U.S.C. 46(f), and FTC Rule 2.34, 16 CFR 2.34,
notice is hereby given that the above-captioned consent agreement
containing a consent order to cease and desist, having been filed with
and accepted, subject to final approval, by the Commission, has been
placed on the public record for a period of 30 days. The following
Analysis to Aid Public Comment describes the terms of the consent
agreement and the allegations in the complaint. An electronic copy of
the full text of the consent agreement package can be obtained at
https://www.ftc.gov/news-events/commission-actions.
You can file a comment online or on paper. For the Commission to
consider your comment, we must receive it on or before February 22,
2023. Write ``Instant Brands LLC; File No. 222 3140'' on your comment.
Your comment--including your name and your state--will be placed on the
public record of this proceeding, including, to the extent practicable,
on the https://www.regulations.gov website.
Because of heightened security screening, postal mail addressed to
the Commission will be subject to delay. We strongly encourage you to
submit your comments online through the https://www.regulations.gov
website.
If you prefer to file your comment on paper, write ``Instant Brands
LLC; File No. 222 3140'' on your comment and on the envelope, and mail
your comment to the following address: Federal Trade Commission, Office
of the Secretary, 600 Pennsylvania Avenue NW, Suite CC-5610 (Annex D),
Washington, DC 20580.
Because your comment will be placed on the publicly accessible
website at https://www.regulations.gov, you are solely responsible for
making sure your comment does not include any sensitive or confidential
information. In particular, your comment should not include sensitive
personal information, such as your or anyone else's Social Security
number; date of birth; driver's license number or other state
identification number, or foreign country equivalent; passport number;
financial account number; or credit or debit card number. You are also
solely responsible for making sure your comment does not include
sensitive health information, such as medical records or other
individually identifiable health information. In addition, your comment
should not include any ``trade secret or any commercial or financial
information which . . . is privileged or confidential''--as provided by
Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2),
16 CFR 4.10(a)(2)--including competitively sensitive information such
as costs, sales statistics, inventories, formulas, patterns, devices,
manufacturing processes, or customer names.
Comments containing material for which confidential treatment is
requested must be filed in paper form, must be clearly labeled
``Confidential,'' and must comply with FTC Rule 4.9(c). In particular,
the written request for confidential treatment that accompanies the
comment must include the factual and legal basis for the request, and
must identify the specific portions of the comment to be withheld from
the public record. See FTC Rule 4.9(c). Your comment will be kept
confidential only if the General Counsel grants your request in
accordance with the law and the public interest. Once your comment
[[Page 3987]]
has been posted on the https://www.regulations.gov website--as legally
required by FTC Rule 4.9(b)--we cannot redact or remove your comment
from that website, unless you submit a confidentiality request that
meets the requirements for such treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
Visit the FTC website at https://www.ftc.gov to read this document
and the news release describing the proposed settlement. The FTC Act
and other laws the Commission administers permit the collection of
public comments to consider and use in this proceeding, as appropriate.
The Commission will consider all timely and responsive public comments
it receives on or before February 22, 2023. For information on the
Commission's privacy policy, including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/site-information/privacy-policy.
Analysis of Proposed Consent Order To Aid Public Comment
The Federal Trade Commission (``FTC'' or ``Commission'') has
accepted, subject to final approval, an agreement containing a consent
order from Instant Brands LLC (``Respondent''). The proposed consent
order has been placed on the public record for 30 days for receipt of
comments from interested persons. Comments received during this period
will become part of the public record. After 30 days, the Commission
will again review the agreement and the comments received and decide
whether it should withdraw from the agreement or make final the
agreement's proposed order.
This matter involves Respondent's advertising of Pyrex measuring
cup sets as ``Made in USA.'' According to the FTC's complaint, between
May 2021 and March 2022, Respondent advertised certain Pyrex measuring
cup sets on Amazon.com as ``Made in USA'' or ``American as Apple Pie,''
even though, in numerous instances, those measuring cup sets were
wholly imported from China. Based on the foregoing, the complaint
alleges Respondent violated section 5 of the FTC Act, 15 U.S.C. 45(a).
The proposed consent order contains provisions designed to prevent
Respondent from engaging in similar acts and practices in the future.
Consistent with the FTC's Made in USA Labeling Rule, 16 CFR part 323,
and its Enforcement Policy Statement on U.S.-Origin Claims, Part I
prohibits Respondent from making U.S.-origin claims for its products
unless: (1) the final assembly or processing of the product occurs in
the United States, all significant processing that goes into the
product occurs in the United States, and all or virtually all
ingredients or components of the product are made and sourced in the
United States; (2) a clear and conspicuous qualification appears
immediately adjacent to the representation that accurately conveys the
extent to which the product contains foreign parts, ingredients or
components, and/or processing; or (3) for a claim that a product is
assembled in the United States, the product is last substantially
transformed in the United States, the product's principal assembly
takes place in the United States, and United States assembly operations
are substantial.
Part II prohibits Respondent from making any representation about
the country of origin of a product or service, unless the
representation is not misleading, and Respondent has a reasonable basis
substantiating it. Parts III and IV are monetary provisions. Part III
imposes a judgment of $129,416. Part IV includes additional monetary
provisions relating to collections.
Parts V through VIII are reporting and compliance provisions. Part
V requires Respondent to acknowledge receipt of the order, to provide a
copy of the order to certain current and future principals, officers,
directors, and employees, and to obtain an acknowledgement from each
such person that they have received a copy of the order. Part VI
requires Respondent to file a compliance report within one year after
the order becomes final and to notify the Commission within 14 days of
certain changes that would affect compliance with the order. Part VII
requires Respondent to maintain certain records, including records
necessary to demonstrate compliance with the order. Part VIII requires
Respondent to submit additional compliance reports when requested by
the Commission and to permit the Commission or its representatives to
interview Respondent's personnel.
Finally, Part IX is a ``sunset'' provision, terminating the order
after twenty (20) years, with certain exceptions.
The purpose of this analysis is to aid public comment on the
proposed order. It is not intended to constitute an official
interpretation of the proposed order or to modify its terms in any way.
By direction of the Commission.
Joel Christie,
Acting Secretary.
[FR Doc. 2023-01187 Filed 1-20-23; 8:45 am]
BILLING CODE 6750-01-P